Related Experiment Videos
[Effects of colforsin daropate hydrochloride in patients undergoing coronary artery bypass surgery]
N Hayashida1, S Chihara, E Tayama
1Department of Surgery, Kurume University, Kurume, Japan.
Insights
Colforsin daropate hydrochloride (Adehl) improved hemodynamics and reduced recovery time in cardiac surgery patients. Adehl demonstrated positive inotropic and vasodilator effects without increasing myocardial oxygen demand.
Area of Science:
- Cardiology
- Anesthesiology
- Pharmacology
Background:
- Perioperative hemodynamic management is critical in cardiac surgery.
- Identifying agents with positive inotropic and vasodilatory effects is essential.
Purpose of the Study:
- To evaluate the hemodynamic and clinical effects of colforsin daropate hydrochloride (Adehl) in patients undergoing coronary artery bypass grafting.
- To assess Adehl's safety profile during the perioperative period.
Main Methods:
- A prospective study involving 26 patients undergoing coronary artery bypass grafting.
- Patients were divided into two groups: control (no Adehl) and Adehl group (infused at 0.5 microgram.kg-1.min-1 for 6 hours).
- Perioperative hemodynamic measurements and clinical outcomes were analyzed.
Main Results:
- The Adehl group showed significantly lower pulmonary capillary wedge pressure and systemic vascular resistance.
- Significantly greater cardiac indices and left ventricular stroke work indices were observed in the Adehl group.
- The Adehl group experienced shorter intubation duration and ICU stay with no significant increase in adverse effects.
Conclusions:
- Adehl exhibits positive inotropic and vasodilator effects in cardiac surgery patients.
- Adehl does not increase myocardial oxygen consumption.
- Adehl may be a beneficial agent for perioperative management in patients undergoing cardiac surgery.
Abstract:
The effects of Adehl, colforsin daropate hydrochloride, on hemodynamics were studied in patients undergoing cardiac surgery. Twenty-six patients who underwent coronary artery bypass grafting were divided into two groups according to the intraoperative administration of Adehl. The control group (n = 14) received no Adehl treatment and the Adehl group (n = 12) received Adehl infusion immediately after anesthesia induction (0.5 microgram.kg-1.min-1) for 6 hours. Hemodynamic measurements and clinical results were accessed perioperatively. The Adehl group resulted in significantly (p < 0.05) lower pulmonary capillary wedge pressure and systemic vascular resistance, and significantly (p < 0.05) greater cardiac indices and left ventricular stroke work indices than those in the control group. No significant difference was found in the rate pressure product between the groups. The Adehl group resulted in significantly shorter duration of intubation and ICU stay. Adehl was not associated with a significant increase in the prevalence of adverse effects. The results suggest that Adehl has positive inotropic and vasodilator effects without increasing myocardial oxygen consumption. Thus, it is suggested that Adehl can be a useful agent for the perioperative management in patients undergoing cardiac surgery.